Tarsons Products Limited IPO Details

Tarsons IPO: Key Details

Note: We neither trade nor encourage our readers to trade in the Grey Market. We share the GMP information for educational purposes only, so that, you can make an informed decision.

Company Information

Tarsons Products Limited is an Indian labware company engaged in the designing, development, manufacturing, and marketing of ‘consumables’, ‘reusables’ and ‘others’ including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations (“CROs”), Diagnostic companies, and hospitals.

Their product portfolio is classified into three key categories which include consumables, reusables, and others.

• ‘Consumables’ category includes products such as centrifuge ware, cryogenic ware, liquid handling, PCR consumables and petri dish, transfer pipettes and others.
• ‘Reusables’ category includes products such as bottles, carboys, beakers, measuring cylinders and tube
  racks.
• ‘Others’ category includes benchtop instrumentation such as vortex shakers, centrifuges pipettors and others

Competitive Strengths

• Leading Indian Supplier to life sciences sector;
• Range of labware products across varied customer segments;
• Operating in an industry which has an addressable market;
• Well-equipped and automated manufacturing facilities;
• Geographic reach through strong sales and distribution network;
• Experienced Promoter backed by a strong management team

Company Strategy

• Strengthening the foothold in existing markets and expanding the product portfolio
• Enhancing manufacturing capacities in existing product categories to leverage industry growth drivers
• Increasing global footprint in the overseas market
• Continue to focus on maintaining operational efficiency and profitability

Proceeds from Tarsons IPO will be used to:

• Repayment/prepayment of all or certain of their borrowings;
• Funding a part of the capital expenditure for the new manufacturing facility at Panchla, West Bengal (the “Proposed Expansion”); and
• General corporate purposes

Tarsons IPO: Financials

Tarsons IPO: Comparison with listed industry peers

As per RHP, there are no listed companies in India whose business portfolio is comparable with that of Fino Payment’s business and comparable to the scale of its operations.

Tarsons IPO: Risks

• Any failure by us to comply with high-quality standards may have an adverse effect on demand from end customers and on reputation,
• The company imports over 75.00% of its raw material
• The geographical concentration of manufacturing facilities, with 86.32% of the total manufacturing revenue contributed by units located at Dhulagarh and Jangalpur
• The manufacturing facility, located in Jalan Industrial Complex at Jangalpur, which contributed 58.00% of the total sale realization of the Company, in Fiscal 2021 is situated on land for which the Company has received approval for conversion of partial land. The requisite approvals for conversion of the remaining land, have been pending since 2006.
• Any inability to implement enhanced and efficient manufacturing processes in business operations as per industry standards could affect the business

For complete internal and external risk factors, you can refer to the RHP of the company.

Tarsons IPO: Registrar and Lead Managers